HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kiren Ubhi Selected Research

Peptides (Polypeptides)

7/2015Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer disease.
8/2011Recent advances in the development of immunotherapies for tauopathies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kiren Ubhi Research Topics

Disease

12Parkinson Disease (Parkinson's Disease)
01/2015 - 02/2010
12Dementia (Dementias)
07/2014 - 02/2010
11Neurodegenerative Diseases (Neurodegenerative Disease)
07/2014 - 08/2008
10Alzheimer Disease (Alzheimer's Disease)
07/2015 - 05/2009
10Multiple System Atrophy
11/2014 - 08/2008
5Synucleinopathies
02/2014 - 02/2010
2Tauopathies
11/2015 - 08/2011
2Memory Disorders (Memory Loss)
07/2014 - 11/2011
2Lewy Body Disease (Lewy Body Dementia)
03/2013 - 04/2011
1Pick Disease of the Brain (Pick's Disease)
11/2015
1Corticobasal Degeneration
03/2014
1Huntington Disease (Huntington's Disease)
03/2014
1Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
03/2014
1Gliosis
02/2014
1Nervous System Diseases (Neurological Disorders)
04/2012
1Amyloid Plaque
11/2011
1Stroke (Strokes)
01/2011
1Narcolepsy
08/2010
1Sleep Wake Disorders
08/2010
1Disorders of Excessive Somnolence (Hypersomnia)
08/2010
1Cognitive Dysfunction
07/2010
1Atrophy
04/2010
1Parkinsonian Disorders (Parkinsonism)
09/2009
1Cerebellar Ataxia (Dysmetria)
09/2009
1Rett Syndrome (Rett's Disorder)
10/2008
1Neurodevelopmental Disorders
10/2008

Drug/Important Bio-Agent (IBA)

16alpha-SynucleinIBA
11/2014 - 08/2008
8Amyloid (Amyloid Fibrils)IBA
11/2015 - 05/2009
8SynucleinsIBA
01/2015 - 11/2010
7cerebrolysinIBA
11/2015 - 10/2008
6Proteins (Proteins, Gene)FDA Link
11/2015 - 05/2009
3Amyloid beta-PeptidesIBA
05/2014 - 05/2009
2NeuropeptidesIBA
11/2015 - 01/2015
2Peptides (Polypeptides)IBA
07/2015 - 08/2011
2Nerve Growth Factors (Neurotrophins)IBA
11/2011 - 05/2010
1Neuroprotective AgentsIBA
11/2015
1AntibodiesIBA
07/2014
1Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
07/2014
1MicroRNAs (MicroRNA)IBA
03/2014
1Reducing AgentsIBA
02/2014
1Antidepressive Agents (Antidepressants)IBA
02/2014
1CytokinesIBA
02/2014
1Nerve Growth Factor (NGF)IBA
02/2013
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
02/2013
1Cholinergic Agents (Cholinergics)IBA
02/2013
1Fluoxetine (Prozac)FDA LinkGeneric
04/2012
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
04/2012
1Pyrrolidonecarboxylic Acid (Pyroglutamic Acid)IBA
01/2012
1Monoclonal AntibodiesIBA
01/2012
1SynaptophysinIBA
11/2010
1OrexinsIBA
08/2010
1Lovastatin (Mevacor)FDA LinkGeneric
02/2010
1CholesterolIBA
02/2010
1AcidsIBA
09/2009
1CalciumIBA
05/2009
1GTP-Binding Proteins (G-Protein)IBA
05/2009
1Protein CIBA
05/2009
1Carrier Proteins (Binding Protein)IBA
10/2008
1Rifampin (Rifampicin)FDA LinkGeneric
08/2008

Therapy/Procedure

2Therapeutics
07/2015 - 01/2015
2Immunotherapy
07/2014 - 08/2011
1Aftercare (After-Treatment)
11/2011
1Investigational Therapies (Experimental Therapy)
01/2011